atopic dermatitis
Where Scientific Innovation, Discovery and Clinical Dermatology Converge
Michael Rosenblum, MD, PhD, was a 20-year-old undergraduate at the University of British Columbia when his mother became ill with breast cancer. At the time, physician-scientists were just beginning to explore how the immune system could be directed to target cancer cells. At the forefront was Dr. Steven Rosenberg, who had written a book that…
Dr. Donald A. Glass II Receives the 2024 DF Sanofi and Regeneron Diversity, Equity, and Inclusion Mid-Career Award
Donald A. Glass II, MD, PhD, has received the first 2024 DF Sanofi and Regeneron Diversity, Equity, and Inclusion Mid-Career Award (SRDEI) from the Dermatology Foundation (DF). The award funds research of exceptional mid-career investigators and comes with funding of $100,000 each year for three years to support basic, clinical, or translational research that leads…
Dr. Marlys Fassett Receives the 2024 DF Bristol Myers Squibb Psoriasis Research Award
Marlys Fassett, MD, PhD, has received the 2024 DF Bristol Myers Squibb Psoriasis Research Award (BMSRA) from the Dermatology Foundation. Dr. Fassett is the second recipient of this prestigious award for extraordinary mid-career investigators. The award comes with $100,000 funding each year for three years to support her research into the role the cytokine IL-31…
The Diversity of Skin
In March 2022, Dr. Callender received the Dermatology Foundation’s Clark W. Finnerud Award presented to an individual who “most skillfully blends clinical practice with writing and teaching dermatology, thereby serving as a mentor and role model.”
New Topical Therapies for Psoriasis and Atopic Dermatitis
Dr. Bhutani presented new topical therapies for psoriasis and atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib.
OFF Label ON Children
Dr. Treat presented off-label uses of systemic medications for rare and common pediatric diseases.